Document resource
Introduction Air pollution harms health, especially for children with asthma. In the UK, it contributes to 30,000 deaths annually and costs the economy £27 billion annually. Newham is in the top 10 places in the UK for air pollution, and the worst in North East London (NEL) with over 10 child deaths relating to asthma in NEL since 2017, and the highest proportion of high-risk asthma patients in NEL.This project aimed to evaluate the impact of a pharmacist-led consultations with patients and their representatives in Newham.Methods Community pharmacists completed opportunistic, or GP-referred conversations with high-risk children under 18 prescribed an inhaler (based on inhaler and medication use/prescriptions). Conversations included inhaler education including use and their carbon footprint alongside pollution exposure. Resources used included the ‘Air Pollution and You’ leaflet and DEFRA’s air aware tool.A retrospective cross-sectional study assessed implementation at participating pharmacies. Quantitative data was recorded in the pharmacy collection tool PharmOutcomes from November 2023 to May 2025; with patient representative feedback via Microsoft Forms survey collected January-May 2025.Results From 602 interventions recorded on PharmOutcomes, 39% of these were referrals from primary care. From 602, 41% had been prescribed >three SABA inhalers in the past year, with 35% being under 8-years-old. In all consultations inhalation technique was checked, with corrections identified in 84% of conversations.From 75 survey responses 67% found both the discussion about the leaflet plus having inhaler technique checked useful. From the leaflet, using quieter roads was agreed by all, 81% encouraged less use of the car, 73% agreed to turn the car engine off when not moving and change cleaning habits. Notably, 93% agreed the actions improved asthma symptoms.Abstract P143 Figure 1‘Air Pollution and You’ leafletConclusions Community pharmacist-led consultations support patients understanding of asthma and its management including the impact of air pollution. Patient representatives and patients are keen to make simple changes if they are educated to do so, to improve control, symptoms and outcomes. Further interventions by community pharmacists would be beneficial to support patients and the wider healthcare system.